Pharmaceuticals, Biotechnology and Life Sciences
Spanish contract development and manufacturing organisation (CDMO) @Idifarma has begun its seventh project with Spanish biotechnology company, Palobiofarma.
LEH Pharma, a provider of revolutionary ocular implants for macular disorders, has picked Syneos Health, a fully integrated biopharmaceutical solutions organization, as its Global Clinical Development and Commercialisation Provider.
Hemogenyx and Orgenesis have entered into collaboration on the further development of Human Postnatal Hemogenic Endothelial Cell technology
Neovacs will continue the development of its IFNalpha Kinoid in South Korea with its partner Chong Kun Dang (CKD) Pharmaceutical Corp, on the basis of the licensing agreement signed in December 2015, for a potential overall value of €5M, the company said Thursday.
Sanofi and Regeneron has gotten the approval from the U.S. Food and Drug Administration (FDA) for Biologics License Application (sBLA) for Praluent Injection, a PCSK9 inhibitor.
Foamix Pharmaceuticals showed its topline results of its third Phase 3 clinical trial (FX2017-22) of FMX101 for the treatment of moderate-to-severe acne.
PureTech Health and its affiliate Karuna have completed a $42 million Series A financing round, which will be used to…
Amryt ensure US Food and Drug Administration’s grant a Rare Pediatric Disease designation for its lead development asset AP101, for…
Sanofi reported €762m of net income in the second quarter 2018, after net sales of €8,176 million, down 5.7% on a…
4D pharma showed that specific single bacterial strains from the human gut microbiota can serve as therapeutic inhibitors of the…